Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.770
-0.090 (-1.85%)
Nov 20, 2024, 4:00 PM EST - Market closed
Tenax Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 5.73 | 5.01 | 5.68 | 6.38 | 5.31 | 5.08 | |
Research & Development | 9.81 | 3.23 | 5.38 | 25.15 | 4.56 | 3.47 | |
Operating Expenses | 15.54 | 8.23 | 11.05 | 31.53 | 9.87 | 8.56 | |
Operating Income | -15.54 | -8.23 | -11.05 | -31.53 | -9.87 | -8.56 | |
Interest Expense | -0.03 | -0.02 | -0 | -0 | -0 | - | |
Interest & Investment Income | 0.52 | - | - | - | - | 0.14 | |
Other Non Operating Income (Expenses) | 0.49 | 0.55 | 0.01 | 0.02 | 0.03 | 0.02 | |
EBT Excluding Unusual Items | -14.56 | -7.71 | -11.05 | -31.51 | -9.84 | -8.4 | |
Gain (Loss) on Sale of Investments | - | - | - | -0.01 | -0.01 | 0 | |
Gain (Loss) on Sale of Assets | -0 | -0 | 0 | - | - | -0 | |
Other Unusual Items | - | - | - | -0.95 | - | - | |
Pretax Income | -14.56 | -7.71 | -11.05 | -32.47 | -9.85 | -8.39 | |
Net Income | -14.56 | -7.71 | -11.05 | -32.47 | -9.85 | -8.39 | |
Net Income to Common | -14.56 | -7.71 | -11.05 | -32.47 | -9.85 | -8.39 | |
Shares Outstanding (Basic) | 6 | 0 | 0 | 0 | - | - | |
Shares Outstanding (Diluted) | 6 | 0 | 0 | 0 | - | - | |
Shares Change (YoY) | 3389.71% | 1250.92% | 43.00% | - | - | - | |
EPS (Basic) | -2.32 | -31.04 | -600.72 | -2525.03 | - | - | |
EPS (Diluted) | -2.32 | -31.04 | -600.72 | -2525.03 | - | - | |
Free Cash Flow | - | -5.9 | -11.39 | -10.86 | -9.28 | -7.56 | |
Free Cash Flow Per Share | - | -23.76 | -619.37 | -844.53 | - | - | |
EBITDA | -15.53 | -8.23 | -11.05 | -31.52 | -9.86 | -8.55 | |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.01 | |
EBIT | -15.54 | -8.23 | -11.05 | -31.53 | -9.87 | -8.56 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.